Small Molecules
27 March 2014
CymaBay Initiates Arhalofenate Phase 2b Gout Study26 March 2014
Avanir Pharmaceuticals Announces Acceptance of New Drug Application for AVP-825 for the Acute Treatment of Migraine26 March 2014
Mast Therapeutics Initiates Phase 2 Study Of MST-188 In Patients With Acute Limb Ischemia26 March 2014
Regulatory update: combined use of Mekinist™ (trametinib) and Tafinlar® (dabrafenib) in Europe25 March 2014
ZS Pharma Announces Start of Enrollment of Phase 3 Extended Dosing Study of ZS-9 in Patients with Hyperkalemia24 March 2014
ARIAD Announces Initiation of Pivotal Phase 2 ALTA Trial of AP26113 in Patients with Non-Small Cell Lung Cancer24 March 2014
Agios Enrolls First Patient in Phase 1 Study of AG-120 in Advanced Solid Tumors with an IDH1 Mutation21 March 2014
Simeprevir receives positive CHMP opinion for the treatment of adults with chronic hepatitis C in the European Union21 March 2014
FDA approves Otezla to treat psoriatic arthritis21 March 2014
Cellceutix to Initiate Psoriasis Clinical TrialNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports